HELE
Helen of Troy Shareholders Approve Board, Pay Plan as CEO Maps Turnaround
Helen of Troy shareholders approved all four proposals at the company's 2026 annual meeting, including the election of nine directors, an advisory vote on executive compensation, an expansion of the stock incentive plan, and the appointment of Grant Thornton LLP as auditor for fiscal 2027. CEO G. Scott Uzzell said the company faced tariffs, cautious retailers, and shifting trade patterns in fiscal 2026, but responded by diversifying suppliers, streamlining products, generating cash flow, and reducing debt. Fiscal 2027 will serve as the foundation year of a three-phase turnaround focused on reinvesting in priority brands, improving innovation and execution, and moving decision-making closer to consumers through a new general-management structure.
MarketBeat·1dRead more ▾
HELE▲
Helen of Troy beats Q1 estimates and raises fiscal 2027 sales outlook
Helen of Troy reported first-quarter fiscal 2027 results that beat estimates and raised its full-year sales guidance. Adjusted earnings came in at 17 cents per share, surpassing the Zacks Consensus Estimate of 2 cents but down 58.5% from 41 cents a year ago. Net sales rose 8.2% to $402.1 million, exceeding the $375 million consensus, driven by growth in both Home & Outdoor and Beauty & Wellness segments. The company lifted its fiscal 2027 net sales outlook to a range of $1.759 billion to $1.831 billion, up from the prior $1.751 billion to $1.822 billion, while maintaining adjusted earnings guidance of $3.25 to $3.75 per share.
Zacks Investment Research·19dRead more ▾
Bragar Eagel & Squire Reminds Helen of Troy Investors of August 3 Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed against Helen of Troy Limited and the lead plaintiff deadline is August 3, 2026. The lawsuit, filed in the United States District Court for the Western District of Texas, covers purchasers of Helen of Troy common stock between April 24, 2024, and October 8, 2025. The complaint alleges that the company misled investors about the progress and savings from its Project Pegasus restructuring initiative, and that the truth began to emerge on July 9, 2024, when Helen of Troy reported a 49% decline in earnings per share and cut its full-year revenue outlook by over 20%, causing the stock price to drop $24.68 per share, or 27.7%. Investors who suffered losses can contact the firm to discuss their legal rights.
GlobeNewswire·26dRead more ▾
HELE▼
Gross Law Firm Reminds Helen of Troy Investors of August 3, 2026 Lead Plaintiff Deadline
The Gross Law Firm reminds Helen of Troy Limited investors that the lead plaintiff deadline in a pending class action lawsuit is August 3, 2026. The class period runs from April 24, 2024 to October 8, 2025. The complaint alleges that defendants made false or misleading statements about Project Pegasus, claiming it would deliver savings and efficiency when they knew or should have known it was not on track to do so. Shareholders who purchased HELE shares during the class period can register for the case without cost or obligation.
GlobeNewswire·33dRead more ▾
HELE▼
HELE Investors Face August 3, 2026 Lead Plaintiff Deadline in Class Action
Robbins LLP reminds stockholders that a class action has been filed on behalf of all investors who purchased or otherwise acquired Helen of Troy Limited common stock between April 24, 2024 and October 8, 2025. The lawsuit alleges that the company misled investors about the effectiveness of Project Pegasus, a global restructuring program, and that it lacked sufficient resources or budget to achieve its stated goals. On October 9, 2025, Helen of Troy reported second quarter fiscal 2026 results showing an 8.9% year-over-year sales decline and a 51% drop in adjusted earnings per share, causing the stock price to fall $6.90 per share, or 25%. Shareholders who wish to serve as lead plaintiff must file their papers with the court by August 3, 2026.
GlobeNewswire·33dRead more ▾
HELE▼
Portnoy Law Firm Files Class Action Against Helen of Troy Over Project Pegasus Claims
The Portnoy Law Firm has announced a class action lawsuit on behalf of Helen of Troy Limited investors who purchased securities between May 13, 2025 and February 19, 2026. Investors have until August 4, 2026 to file a lead plaintiff motion. The lawsuit alleges that the company made false or misleading statements about its Project Pegasus restructuring program, which was supposed to improve efficiency and effectiveness but allegedly failed to deliver the touted benefits. The complaint points to several financial disclosures, including a 49% drop in earnings per share and a more than 20% reduction in full-year revenue outlook on July 9, 2024, a net sales decline of 11% and a nearly 60% decline in adjusted earnings per share along with a $414.4 million goodwill impairment on July 10, 2025, and an 8.9% year-over-year sales drop with a 51% fall in adjusted earnings per share on October 9, 2025, each triggering significant stock price declines.
GlobeNewswire·36dRead more ▾
Gross Law Firm alerts Helen of Troy shareholders of August 3 deadline in securities class action
The Gross Law Firm has issued a notice to shareholders of Helen of Troy Limited regarding a securities class action, with a lead plaintiff deadline of August 3, 2026. The class period runs from April 24, 2024 to October 8, 2025. The complaint alleges that defendants made false or misleading statements about Project Pegasus, claiming it would deliver savings and efficiency despite knowing or should have known it was not on track to do so given internal and external constraints. Shareholders who purchased HELE shares during the class period can register for the case without cost or obligation.
GlobeNewswire·40dRead more ▾
Portnoy Law Firm Files Class Action Against Helen of Troy Limited
The Portnoy Law Firm has announced a class action lawsuit on behalf of investors who purchased Helen of Troy Limited securities between May 13, 2025 and February 19, 2026. The lawsuit alleges that the company made false or misleading statements about its Project Pegasus restructuring program, failing to disclose that it would not achieve the touted savings and efficiencies. Investors have until August 4, 2026 to file a lead plaintiff motion. The complaint points to several stock drops following disappointing financial results, including a nearly 28% decline on July 9, 2024 after a 49% year-over-year earnings per share decrease, a nearly 23% drop on July 10, 2025 after an 11% net sales decline and a $414.4 million goodwill impairment, and a 25% fall on October 9, 2025 after an 8.9% sales decline and a 51% drop in adjusted earnings per share.
GlobeNewswire·43dRead more ▾
Helen of Troy raises fiscal 2027 net sales outlook to $1.759B-$1.831B
Helen of Troy has raised its fiscal 2027 net sales guidance to a range of $1.759 billion to $1.831 billion, up from the prior forecast of $1.751 billion to $1.822 billion, while maintaining adjusted earnings per share of $3.25 to $3.75. The company also kept its adjusted EBITDA outlook at $190 million to $197 million and free cash flow at $85 million to $100 million. First-quarter consolidated sales rose 8.2%, driven by 9.5% growth in Home & Outdoor and 7% in Beauty & Wellness, though gross margin contracted 110 basis points to 46% due to tariffs and a less favorable customer mix. Management cited revenue risk from expected supply disruptions tied to Middle East conflict and said it is not yet assuming benefits from future tariff-refund phases beyond the approximately $9.2 million Phase 1 pretax refund embedded in the outlook.
Seeking Alpha·49dRead more ▾
Helen of Troy beats Q1 estimates, raises fiscal 2027 sales outlook
Helen of Troy reported first-quarter fiscal 2027 non-GAAP earnings per share of 17 cents, beating estimates by 15 cents, while revenue rose 8.2 percent year-over-year to 402.1 million dollars, exceeding consensus by 27.55 million dollars. The company raised its full-year consolidated net sales guidance to a range of 1.759 billion to 1.831 billion dollars, above the 1.79 billion dollar consensus. It maintained its adjusted diluted earnings per share outlook of 3.25 to 3.75 dollars, compared to a 3.49 dollar consensus, and kept its adjusted EBITDA forecast at 190 to 197 million dollars. GAAP net income is expected between 85 and 100 million dollars, with cash flow from operations of 119 to 130 million dollars and free cash flow of 85 to 100 million dollars.
Seeking Alpha·49dRead more ▾
HELE▼
Levi Strauss and Helen of Troy to report pre-market earnings July 8
Levi Strauss & Co. and Helen of Troy Limited are scheduled to report earnings before the market opens on July 8, 2026. Levi Strauss, a retail shoe company, is expected to post earnings per share of $0.24 for the quarter ending May 31, 2026, based on five analysts' consensus, representing a 9.09% increase from the same quarter last year. The company has beaten expectations every quarter in the past year, with the highest beat of 13.51% in the first calendar quarter. Helen of Troy, a cosmetic and toiletries company, is forecast to report a loss of $0.13 per share for the same quarter, a 132.50% decline from the prior year, according to three analysts.
Zacks Investment Research·50dRead more ▾
HELE▼
Pomerantz Law Firm Reminds Helen of Troy Investors of Class Action Lawsuit and August 3 Deadline
Pomerantz LLP has filed a class action lawsuit against Helen of Troy Limited, alleging securities fraud or other unlawful business practices. Investors who purchased or acquired Helen of Troy securities during the Class Period have until August 3, 2026, to seek appointment as Lead Plaintiff. The complaint follows a series of disappointing financial disclosures, including a 49% drop in earnings per share and a more than 20% reduction in full-year revenue outlook on July 9, 2024, which caused the stock to fall nearly 28%. On July 10, 2025, the company reported an 11% net sales decline, a nearly 60% drop in adjusted earnings per share, and a $414.4 million goodwill impairment, leading to a nearly 23% stock decline. On October 9, 2025, quarterly sales fell 8.9%, adjusted earnings per share dropped 51%, and the company warned of ongoing disruptions and cost headwinds, resulting in a 25% stock drop.
GlobeNewswire·57dRead more ▾
HELE
Zacks Names Five Beauty Stocks to Buy for Second-Half 2026
Zacks Investment Research recommends five beauty and cosmetics stocks for a stable portfolio in the second half of 2026, all carrying a Zacks Rank of 1 (Strong Buy) or 2 (Buy). The picks are Estée Lauder, Helen of Troy, Nu Skin Enterprises, Kenvue, and Interparfums. Estée Lauder, the sole Strong Buy, is expected to see earnings grow 31.9% in its fiscal year ending June 2027, driven by its Profit Recovery and Growth Plan and digital expansion. Kenvue's earnings estimate has risen 5.5% over the past 60 days, with projected revenue growth of 3.2%. The other three companies face near-term revenue or earnings declines, but are supported by strategic initiatives such as portfolio optimization and channel expansion.
Zacks Investment Research·57dRead more ▾
HELE▼
Helen of Troy investors face August 3 lead plaintiff deadline in securities class action
A securities class action lawsuit has been filed against Helen of Troy Limited, and investors who purchased HELE shares between April 24, 2024, and October 8, 2025, have until August 3, 2026, to seek appointment as lead plaintiff. The suit follows share price declines of 27.7% on July 9, 2024, 22.7% on July 10, 2025, and 25% on October 9, 2025. Under the Private Securities Litigation Reform Act, the court typically selects the applicant with the largest financial interest to direct the litigation on behalf of the entire class, with no minimum loss threshold required. Investors who do not seek lead plaintiff status remain absent class members and are automatically included in any potential recovery without needing to take action at this time.
GlobeNewswire·64dRead more ▾
HELE▼
Bragar Eagel & Squire Reminds Helen of Troy Investors of Class Action Deadline
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed against Helen of Troy Limited on behalf of purchasers of its common stock between April 24, 2024, and October 8, 2025. The lawsuit alleges that the company misled investors about the progress and benefits of its Project Pegasus restructuring initiative, which was not delivering the touted efficiencies and lacked sufficient resources to meet stated goals. The truth began to emerge on July 9, 2024, when Helen of Troy reported a 49% decline in earnings per share and cut its full-year revenue outlook by over 20%, causing its share price to drop $24.68, or 27.7%. Investors have until August 3, 2026, to seek appointment as lead plaintiff.
GlobeNewswire·65dRead more ▾
Zacks Highlights Estee Lauder, e.l.f. Beauty, Helen of Troy and Nu Skin Amid Favorable Cosmetics Trends
Zacks Equity Research has identified The Estee Lauder Companies, e.l.f. Beauty, Helen of Troy, and Nu Skin Enterprises as cosmetics stocks worth watching, citing favorable industry trends. The Zacks Cosmetics industry is benefiting from sustained demand for skincare, makeup, fragrance, and personal care products, driven by consumers' focus on self-care and wellness. Innovation in science-backed formulations and clean beauty, along with digital engagement tools, is fueling growth, though companies face cautious spending, elevated input costs, and supply-chain uncertainties. The industry carries a Zacks Industry Rank of 107, placing it in the top 43% of over 247 industries, and its consensus earnings estimate for the current fiscal year has risen 17% since early April 2026. Estee Lauder, rated Zacks Rank #2, has a consensus EPS estimate of $2.41 and its stock gained 17.1% over the past year; Helen of Troy, also Rank #2, has an EPS estimate of $3.44 and an 8.4% gain; Nu Skin, Rank #3, has an EPS estimate of $1.00 and a 35% decline; and e.l.f. Beauty, Rank #3, saw its EPS estimate drop 8.6% to $3.30 and its stock fall 46.7%.
Zacks Investment Research·70dRead more ▾